Teladoc Health, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-106.8M | $-74.2M | $-58.0M | $-17.0M | $-6.0M |
| Depreciation & Amortization | $19.1M | $8.3M | $4.9M | $2.3M | $754.0K |
| Depreciation | $3.8M | $2.2M | $1.1M | $300.0K | $200.0K |
| Amortization | $15.3M | $6.1M | $3.7M | $2.0M | $600.0K |
| Stock-Based Compensation | $30.6M | $7.7M | $3.1M | $533.0K | $298.0K |
| Net Cash from Operating Activities | $-34.4M | $-51.9M | $-47.2M | $-11.4M | $-6.1M |
| Investing Activities | |||||
| Capital Expenditures | $2.6M | $2.1M | $6.3M | $1.1M | $204.0K |
| Business Acquisitions | $379.4M | $37.0M | $17.8M | $13.8M | $16.5M |
| Net Cash from Investing Activities | $-448.4M | $26.1M | $-108.2M | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | $368.0K | $71.0K |
| Net Cash from Financing Activities | $475.4M | $20.7M | $164.0M | — | — |
| Net Change in Cash | — | — | — | — | — |
| Free Cash Flow | $-37.1M | $-54.0M | $-53.5M | $-12.4M | $-6.3M |